Literature DB >> 28867754

Sushi repeat-containing protein X-linked 2 promotes angiogenesis through the urokinase-type plasminogen activator receptor dependent integrin αvβ3/focal adhesion kinase pathways.

Kuiliang Liu1, Jianghao Fan1, Jing Wu1.   

Abstract

Sushi repeat-containing protein X-linked 2 (SRPX2) is a newly identified chondroitin sulfate proteoglycan that is markedly elevated in multiple solid tumors. It is also suggested that SRPX2 is associated with angiogenesis. A conditioned medium of SRPX2 overexpressing colorectal cancer (CRC) cells and SRPX2 recombinant protein was used to evaluate the effect of secretory SRPX2 on the angiogenesis ability of human umbilical vein endothelial cells (HUVECs) and the involved molecular mechanisms. It was revealed that the activity of SRPX2 is dependent on the urokinase-type plasminogen activator receptor and cooperation of the integrin αvβ3 co-receptor. Subsequent studies showed that both PI3K/Akt and Ras/MAPK pathways and phosphorylation of focal adhesion kinase is involved in the intracellular signaling pathway of SRPX2/uPAR. This study suggests that SRPX2 promotes angiogenesis of HUVECs through the cooperation of the uPAR and integrin/FAK pathway.

Entities:  

Keywords:  SRPX2; angiogenesis; extracellular matrix; proteoglycan

Mesh:

Substances:

Year:  2017        PMID: 28867754     DOI: 10.5582/ddt.2017.01017

Source DB:  PubMed          Journal:  Drug Discov Ther        ISSN: 1881-7831


  8 in total

1.  Transcriptome signature of cellular senescence.

Authors:  Gabriel Casella; Rachel Munk; Kyoung Mi Kim; Yulan Piao; Supriyo De; Kotb Abdelmohsen; Myriam Gorospe
Journal:  Nucleic Acids Res       Date:  2019-08-22       Impact factor: 16.971

2.  Gene-Specific Intron Retention Serves as Molecular Signature that Distinguishes Melanoma from Non-Melanoma Cancer Cells in Greek Patients.

Authors:  Aikaterini F Giannopoulou; Eumorphia G Konstantakou; Athanassios D Velentzas; Socratis N Avgeris; Margaritis Avgeris; Nikos C Papandreou; Ilianna Zoi; Vicky Filippa; Stamatia Katarachia; Antonis D Lampidonis; Anastasia Prombona; Popi Syntichaki; Christina Piperi; Efthimia K Basdra; Vassiliki Iconomidou; Evangelia Papadavid; Ema Anastasiadou; Issidora S Papassideri; Athanasios G Papavassiliou; Gerassimos E Voutsinas; Andreas Scorilas; Dimitrios J Stravopodis
Journal:  Int J Mol Sci       Date:  2019-02-21       Impact factor: 5.923

Review 3.  The uPAR System as a Potential Therapeutic Target in the Diseased Eye.

Authors:  Maurizio Cammalleri; Massimo Dal Monte; Vincenzo Pavone; Mario De Rosa; Dario Rusciano; Paola Bagnoli
Journal:  Cells       Date:  2019-08-18       Impact factor: 6.600

4.  Sushi Repeat Containing Protein X-linked 2 Is a Downstream Signal of LEM Domain Containing 1 and Acts as a Tumor-Promoting Factor in Oral Squamous Cell Carcinoma.

Authors:  Tomonori Sasahira; Miyako Kurihara-Shimomura; Yukiko Nishiguchi; Hiroyuki Shimomura; Tadaaki Kirita
Journal:  Int J Mol Sci       Date:  2020-05-22       Impact factor: 5.923

5.  SRPX2 boosts pancreatic cancer chemoresistance by activating PI3K/AKT axis.

Authors:  Zhenyuan Gao; Jisong Wu; Xiao Wu; Jialei Zheng; Yimei Ou
Journal:  Open Med (Wars)       Date:  2020-10-22

Review 6.  Urokinase-type plasminogen activator receptor (uPAR) as a therapeutic target in cancer.

Authors:  Bing-Tao Zhai; Huan Tian; Jing Sun; Jun-Bo Zou; Xiao-Fei Zhang; Jiang-Xue Cheng; Ya-Jun Shi; Yu Fan; Dong-Yan Guo
Journal:  J Transl Med       Date:  2022-03-18       Impact factor: 5.531

Review 7.  Sushi-Repeat-Containing Protein X-Linked 2: A Potential Therapeutic Target for Inflammation and Cancer Therapy.

Authors:  Jinhua Chen; Zhenhua Yin; Wenping Song; Baoxia He; Wenzhou Zhang
Journal:  J Immunol Res       Date:  2022-07-28       Impact factor: 4.493

8.  Dysregulated Expression of Three Genes in Colorectal Cancer Stratifies Patients into Three Risk Groups.

Authors:  Alba Rodriguez; Luís Antonio Corchete; José Antonio Alcazar; Juan Carlos Montero; Marta Rodriguez; Luis Miguel Chinchilla-Tábora; Rosario Vidal Tocino; Carlos Moyano; Saray Muñoz-Bravo; José María Sayagués; Mar Abad
Journal:  Cancers (Basel)       Date:  2022-08-23       Impact factor: 6.575

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.